Back

Indications for SGLT2i to prevent cardiovascular toxicity

21 June 2025 (17:12 - 17:25)
Organised by: Logo
Congress Presentation Part of: Virtual guidelines task force Cardiovascular Toxicity Monitoring CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Professor Ana Abreu

Hospital de Santa Maria Faculty of Medicine, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Virtual guidelines taskforces
Slides Video
Presentation thumbnail
Role of GLP-1 in cardio-oncology
Assistant Professor D. Farmakis (Athens, GR)
Slides Video
Presentation thumbnail
Troponin monitoring during immune checkpoint inhibitors treatment
Doctor W. Meijers (Rotterdam, NL)
Slides Video
Presentation thumbnail
Ejection fraction vs. global longitudinal strain for cancer treatment surveillance
Professor A. Barac (Fairfax, US)
Slides Video

Access the full session

Session thumbnail
Virtual guidelines task force

The Event

Event poster

ESC Cardio-Oncology 2025

21 June 2025 17:12 CET
You may be interested in
thumbnail
Congress Presentation
Role of GLP-1 in cardio-oncology
thumbnail
Congress Presentation
Troponin monitoring during immune checkpoint inhibitors treatment
thumbnail
Congress Presentation
Ejection fraction vs. global longitudinal strain for cancer treatment surveillance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources